Assuming 30 trading days horizon, Biopath Holdings Inc is expected to generate 0.87 times more return on investment than Adamis. However, Biopath Holdings Inc is 1.15 times less risky than Adamis. It trades about 0.16 of its potential returns per unit of risk. Adamis Pharmaceuticals Corporation is currently generating about 0.09 per unit of risk. If you would invest 27.00 in Biopath Holdings Inc on April 25, 2012 and sell it today you would earn a total of 7.00 from holding Biopath Holdings Inc or generate 25.93% return on investment over 30 days.
Diversification
Good diversification
Overlapping area represents amount of risk that can be diversified away by holding Biopath Holdings Inc and Adamis Pharmaceuticals Corp. in the same portfolio (assuming nothing else is changed)
94% of all equities and portfolios perform better than Biopath Holdings Inc. Compared with the overall equity markets, risk-adjusted returns on investments in Biopath Holdings Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 30 days.
97% of all equities and portfolios perform better than Adamis Pharmaceuticals Corporation. Compared with the overall equity markets, risk-adjusted returns on investments in Adamis Pharmaceuticals Corporation are ranked lower than 3 (%) of all global equities and portfolios over the last 30 days.
USA 
Select Assests
Optimize Portfolio
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatilities
Import Equities
Search Equities
